BRPI0513845A - aglomeração de partìculas de esterol tendo um tamanho particular - Google Patents

aglomeração de partìculas de esterol tendo um tamanho particular

Info

Publication number
BRPI0513845A
BRPI0513845A BRPI0513845-0A BRPI0513845A BRPI0513845A BR PI0513845 A BRPI0513845 A BR PI0513845A BR PI0513845 A BRPI0513845 A BR PI0513845A BR PI0513845 A BRPI0513845 A BR PI0513845A
Authority
BR
Brazil
Prior art keywords
sterol
agglomeration
particular size
sterol particles
particles
Prior art date
Application number
BRPI0513845-0A
Other languages
English (en)
Inventor
Matthew Deguise
Luke Stevens
Original Assignee
Cargill Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cargill Inc filed Critical Cargill Inc
Publication of BRPI0513845A publication Critical patent/BRPI0513845A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11Plant sterols or derivatives thereof, e.g. phytosterols
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23PSHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P10/00Shaping or working of foodstuffs characterised by the products
    • A23P10/20Agglomerating; Granulating; Tabletting
    • A23P10/22Agglomeration or granulation with pulverisation of solid particles, e.g. in a free-falling curtain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • A61K9/1688Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)

Abstract

AGLOMERAçãO DE PARTìCULAS DE ESTEROL TENDO UM TAMANHO PARTICULAR. A presente invenção refere-se a aglomerados de partículas de esterol compreendendo partículas de esterol tendo um tamanho médio de partícula igual ou menor do que cerca de 100 mícrons. São também descritos métodos para a produção dos aglomerados de partículas de esterol que incluem contato das partículas de esterol com um líquido ou um líquido e aglutinante e secagem da dispersão resultante.
BRPI0513845-0A 2004-08-13 2005-08-12 aglomeração de partìculas de esterol tendo um tamanho particular BRPI0513845A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/918,766 US20060034934A1 (en) 2004-08-13 2004-08-13 Agglomeration of sterol particles
PCT/US2005/029033 WO2006020980A1 (en) 2004-08-13 2005-08-12 Agglomeration of sterol particles having a particular size

Publications (1)

Publication Number Publication Date
BRPI0513845A true BRPI0513845A (pt) 2008-05-20

Family

ID=35432815

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513845-0A BRPI0513845A (pt) 2004-08-13 2005-08-12 aglomeração de partìculas de esterol tendo um tamanho particular

Country Status (6)

Country Link
US (1) US20060034934A1 (pt)
EP (1) EP1796645A1 (pt)
JP (1) JP2008509934A (pt)
AU (1) AU2005272564A1 (pt)
BR (1) BRPI0513845A (pt)
WO (1) WO2006020980A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4773720B2 (ja) * 2002-06-12 2011-09-14 ザ・コカ−コーラ・カンパニー 植物ステロール含有飲料
US7306819B2 (en) * 2002-06-12 2007-12-11 The Coca-Cola Company Beverages containing plant sterols
DE102005039836A1 (de) * 2005-08-23 2007-03-01 Cognis Ip Management Gmbh Sterolesterpulver
DE102005039835A1 (de) * 2005-08-23 2007-03-01 Cognis Ip Management Gmbh Pulverförmige Sterolformulierungen mit Kolloidbildnern
DE102006010663A1 (de) * 2006-03-08 2007-09-13 Cognis Ip Management Gmbh Verfahren zur Herstellung sterolhaltiger Pulver
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
EP1929885A1 (de) * 2006-12-04 2008-06-11 Cognis IP Management GmbH Verfahren zur Herstellung von Sterolformulierungen
EP1929884A1 (de) * 2006-12-04 2008-06-11 Cognis IP Management GmbH Verfahren zur Herstellung von Sterolformulierungen
EP2036445A1 (en) * 2007-09-05 2009-03-18 Dietetics Pharma S.r.l. Nutraceutic preparation in powder form containing free plant sterols
EP2036444A1 (en) * 2007-09-05 2009-03-18 Dietetics Pharma S.r.l. Liquid nutraceutic preparation containing free plant sterols
US20090110797A1 (en) * 2007-10-24 2009-04-30 Thomas Gottemoller Dispersible compositions comprising cocoa powder and processes for producing
WO2012092088A1 (en) 2010-12-29 2012-07-05 Abbott Laboratories Nutritional products including a novel fat system including monoglycerides
EP3117720B1 (de) * 2015-05-29 2019-02-20 Symrise AG Grosse agglomeratpartikel

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2897119A (en) * 1957-11-12 1959-07-28 Camp Sea Food Company Inc Van Stable powdered oil soluble vitamins and method of preparing stable powdered oil soluble vitamins
US3881005A (en) * 1973-08-13 1975-04-29 Lilly Co Eli Pharmaceutical dispersible powder of sitosterols and a method for the preparation thereof
JP4612184B2 (ja) * 1997-12-08 2011-01-12 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸不安定な活性化合物を含有する新規の投与形
US6110502A (en) * 1998-02-19 2000-08-29 Mcneil-Ppc, Inc. Method for producing water dispersible sterol formulations
GB0021498D0 (en) * 2000-09-01 2000-10-18 Novartis Nutrition Ag New formulation
US20040052733A1 (en) * 2000-11-30 2004-03-18 Staniforth John Nicholas Pharmaceutical compositions for inhalation
US6773733B2 (en) * 2001-03-26 2004-08-10 Loders Croklaan Usa Llc Structured particulate systems
US6623780B1 (en) * 2002-03-26 2003-09-23 Cargill, Inc. Aqueous dispersible sterol product
WO2003092406A1 (en) * 2002-05-02 2003-11-13 Volker Kuellmer Coated, agglomerated phytochemicals

Also Published As

Publication number Publication date
JP2008509934A (ja) 2008-04-03
US20060034934A1 (en) 2006-02-16
AU2005272564A1 (en) 2006-02-23
EP1796645A1 (en) 2007-06-20
WO2006020980A1 (en) 2006-02-23

Similar Documents

Publication Publication Date Title
BRPI0513845A (pt) aglomeração de partìculas de esterol tendo um tamanho particular
Eom et al. Oxidative stress of silica nanoparticles in human bronchial epithelial cell, Beas-2B
Blechinger et al. Uptake kinetics and nanotoxicity of silica nanoparticles are cell type dependent
Blanco et al. Stability and viscoelasticity of magneto-pickering foams
Sheng et al. Mechanisms of TiO2 nanoparticle‐induced neuronal apoptosis in rat primary cultured hippocampal neurons
Hong et al. Formation of hydrogel particles by thermal treatment of β-lactoglobulin− chitosan complexes
Sinha et al. β-Cyclodextrin functionalized magnetic mesoporous silica colloid for cholesterol separation
BR0005139A (pt) Emulsão cosmética ou dermatológica comportando pelo menos um sistema fotoprotetor, composição cosmética e/ou dermatológica, utilizacao da emulsão e utilização de polìmero associativo
Zhou et al. Role of mucin in behavior of food-grade TiO2 nanoparticles under simulated oral conditions
DE60319073D1 (de) Nanopartikelzusammensetzungen von mitogen-aktivierten protein (map) kinase inhibitoren
MX2009003324A (es) Inmuno-reguladores, preparaciones y composiciones que incluyen los inmuno-reguladores, pruebas para evaluar la actividad de los inmuno-reguladores y preparaciones y composiciones que incluyen los mismos y metodos.
BR0207623A (pt) Composição lìquida
Cai et al. Preparation and characterization of multiresponsive polymer composite microspheres with core–shell structure
BR0005141A (pt) Emulsão cosmetica ou dematológica sem emulsionante, composição cosmética ou dermatológica destinada a fotoproteção da pele e/ou dos cabelos, utilização de emulsão e utilização de um polìmero associativo
Winuprasith et al. Alterations in nanoparticle protein corona by biological surfactants: Impact of bile salts on β-lactoglobulin-coated gold nanoparticles
BRPI0512142A (pt) método para o tratamento de uma formação subterránea, uso de um material, e, composição de tratamento de poço di hidrocarboneto
Mekseriwattana et al. The impact of serum proteins and surface chemistry on magnetic nanoparticle colloidal stability and cellular uptake in breast cancer cells
Liu et al. Biomimetic polymersomes as carriers for hydrophilic quantum dots
Aluani et al. In vitro protective effects of encapsulated quercetin in neuronal models of oxidative stress injury
Hirai et al. Cutaneous exposure to agglomerates of silica nanoparticles and allergen results in IgE-biased immune response and increased sensitivity to anaphylaxis in mice
Song et al. Preparation and characterization of novel quaternized cellulose nanoparticles as protein carriers
Ansari et al. An investigation on the effect of β-CD modified Fe3O4 magnetic nanoparticles on aggregation of amyloid b peptide (25-35)
Chen et al. Characterization of the interactions between protein and carbon black
BRPI0514163A (pt) partìculas de polìmero superabsorvente compreendendo funcionalizantes e método para fabricação das mesmas
Galindo-Gonzalez et al. Elaboration and rheological investigation of magnetic sensitive nanocomposite biopolymer networks

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/56 (2006.01), A23L 33/11 (2016.01), A23P 1